Allergic rhinitis in children

被引:29
作者
Turner, Paul J. [1 ]
Kemp, Andrew S.
机构
[1] Childrens Hosp, Dept Allergy & Immunol, Westmead, NSW 2145, Australia
关键词
allergic rhinitis; child; rhinitis; diagnosis; therapy; AQUEOUS NASAL SPRAY; INTRANASAL CORTICOSTEROIDS; RECEPTOR ANTAGONISTS; SUBLINGUAL IMMUNOTHERAPY; ASTHMA; SAFETY; MANAGEMENT; CETIRIZINE; GUIDELINES; SYMPTOMS;
D O I
10.1111/j.1440-1754.2010.01779.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Allergic rhinitis affects up to 40% of children but is commonly undiagnosed. Careful assessment of nasal symptoms allows for the most appropriate therapeutic options to be chosen. Allergen avoidance is often difficult in practice. Antihistamines are of limited benefit in allergic rhinitis caused by house dust mite and other perennial allergens, where symptoms, predominantly nasal obstruction, are not histamine mediated. In contrast, symptoms triggered by pollen, such as nasal itch, rhinorrhoea and sneezing, are relieved by antihistamines. Intranasal steroids are the treatment of choice for persistent moderatesevere allergic rhinitis and are more effective than antihistamines for relief of nasal obstruction. Failure to respond to intranasal medications is often caused by poor compliance or inefficient use of nasal sprays. Immunotherapy may be a useful, if expensive, option, particularly where symptoms are because of a specific pollen. The benefits of immunotherapy in house dust mite-induced rhinitis and asthma remain controversial.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 46 条
[1]  
Ait-Khaled N, 2007, PEDIAT ALLERGY IMMUN, V19, P110
[2]  
Allen DB, 2002, ALLERGY ASTHMA PROC, V23, P407
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]   Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy [J].
Bufe, Albrecht ;
Eberle, Peter ;
Franke-Beckmann, Eivy ;
Funck, Juergen ;
Kimmig, Martin ;
Klimek, Ludger ;
Knecht, Roland ;
Stephan, Volker ;
Tholstrup, Bente ;
Weisshaar, Christian ;
Kaiser, Friedrich .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) :167-173
[6]   Allergen injection immunotherapy for seasonal allergic rhinitis [J].
Calderon, M. A. ;
Alves, B. ;
Jacobson, M. ;
Hurwitz, B. ;
Sheikh, A. ;
Durham, S. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[8]   Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr [J].
Chen, ST ;
Lu, KH ;
Sun, HL ;
Chang, WT ;
Lue, KH ;
Chou, MC .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (01) :49-54
[9]   Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis [J].
Di Lorenzo, G ;
Pacor, ML ;
Pellitteri, ME ;
Morici, G ;
Di Gregoli, A ;
Lo Bianco, C ;
Ditta, V ;
Martinelli, N ;
Candore, G ;
Mansueto, P ;
Rini, GB ;
Corrocher, R ;
Caruso, C .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (02) :259-267
[10]   Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study [J].
Droste, JHJ ;
Kerkhof, M ;
deMonchy, JGR ;
Schouten, JP ;
Rijcken, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (04) :922-932